Table of Contents

2019-2024 Global Opioid Tolerance Treatment Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Opioid Tolerance Treatment Consumption 2014-2024
  • 2.1.2 Opioid Tolerance Treatment Consumption CAGR by Region
• 2.2 Opioid Tolerance Treatment Segment by Type
  • 2.2.1 NMDA Antagonists
  • 2.2.2 Alpha2-Adrenoceptor Agonists
• 2.3 Opioid Tolerance Treatment Consumption by Type
  • 2.3.1 Global Opioid Tolerance Treatment Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Opioid Tolerance Treatment Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Opioid Tolerance Treatment Sale Price by Type (2014-2019)
• 2.4 Opioid Tolerance Treatment Segment by Application
  • 2.4.1 Hospitals and Ambulatory Surgery Centers
  • 2.4.2 Rehabilitation Centers
• 2.5 Opioid Tolerance Treatment Consumption by Application
  • 2.5.1 Global Opioid Tolerance Treatment Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Opioid Tolerance Treatment Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Opioid Tolerance Treatment Sale Price by Application (2014-2019)

3 Global Opioid Tolerance Treatment by Manufacturers

• 3.1 Global Opioid Tolerance Treatment Sales Market Share by Manufacturers
  • 3.1.1 Global Opioid Tolerance Treatment Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Opioid Tolerance Treatment Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Opioid Tolerance Treatment Revenue Market Share by Manufacturers
  • 3.2.1 Global Opioid Tolerance Treatment Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Opioid Tolerance Treatment Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Opioid Tolerance Treatment Sale Price by Manufacturers
• 3.4 Global Opioid Tolerance Treatment Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Opioid Tolerance Treatment Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Opioid Tolerance Treatment Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Opioid Tolerance Treatment by Regions

• 4.1 Opioid Tolerance Treatment by Regions
  • 4.1.1 Global Opioid Tolerance Treatment Consumption by Regions
  • 4.1.2 Global Opioid Tolerance Treatment Value by Regions
• 4.2 Americas Opioid Tolerance Treatment Consumption Growth
• 4.3 APAC Opioid Tolerance Treatment Consumption Growth
• 4.4 Europe Opioid Tolerance Treatment Consumption Growth
• 4.5 Middle East & Africa Opioid Tolerance Treatment Consumption Growth

5 Americas

• 5.1 Americas Opioid Tolerance Treatment Consumption by Countries
  • 5.1.1 Americas Opioid Tolerance Treatment Consumption by Countries (2014-2019)
  • 5.1.2 Americas Opioid Tolerance Treatment Value by Countries (2014-2019)
• 5.2 Americas Opioid Tolerance Treatment Consumption by Type
• 5.3 Americas Opioid Tolerance Treatment Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Opioid Tolerance Treatment Consumption by Countries
  • 6.1.1 APAC Opioid Tolerance Treatment Consumption by Countries (2014-2019)
  • 6.1.2 APAC Opioid Tolerance Treatment Value by Countries (2014-2019)
• 6.2 APAC Opioid Tolerance Treatment Consumption by Type
• 6.3 APAC Opioid Tolerance Treatment Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Opioid Tolerance Treatment by Countries
  • 7.1.1 Europe Opioid Tolerance Treatment Consumption by Countries (2014-2019)
  • 7.1.2 Europe Opioid Tolerance Treatment Value by Countries (2014-2019)
• 7.2 Europe Opioid Tolerance Treatment Consumption by Type
• 7.3 Europe Opioid Tolerance Treatment Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Opioid Tolerance Treatment by Countries
  • 8.1.1 Middle East & Africa Opioid Tolerance Treatment Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Opioid Tolerance Treatment Value by Countries (2014-2019)
• 8.2 Middle East & Africa Opioid Tolerance Treatment Consumption by Type
• 8.3 Middle East & Africa Opioid Tolerance Treatment Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Opioid Tolerance Treatment Distributors
• 10.3 Opioid Tolerance Treatment Customer

11 Global Opioid Tolerance Treatment Market Forecast

• 11.1 Global Opioid Tolerance Treatment Consumption Forecast (2019-2024)
• 11.2 Global Opioid Tolerance Treatment Forecast by Regions
  • 11.2.1 Global Opioid Tolerance Treatment Forecast by Regions (2019-2024)
  • 11.2.2 Global Opioid Tolerance Treatment Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Opioid Tolerance Treatment Forecast by Type
• 11.8 Global Opioid Tolerance Treatment Forecast by Application

12 Key Players Analysis

• 12.1 Boehringer Ingelheim International
  • 12.1.1 Company Details
  • 12.1.2 Opioid Tolerance Treatment Product Offered
  • 12.1.3 Boehringer Ingelheim International Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Boehringer Ingelheim International News
• 12.2 GlaxoSmithKline
  • 12.2.1 Company Details
  • 12.2.2 Opioid Tolerance Treatment Product Offered
  • 12.2.3 GlaxoSmithKline Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 GlaxoSmithKline News
• 12.3 Teva Pharmaceutical Industries
  • 12.3.1 Company Details
  • 12.3.2 Opioid Tolerance Treatment Product Offered
  • 12.3.3 Teva Pharmaceutical Industries Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Teva Pharmaceutical Industries News
• 12.4 Mylan
  • 12.4.1 Company Details
  • 12.4.2 Opioid Tolerance Treatment Product Offered
  • 12.4.3 Mylan Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Mylan News
• 12.5 Otsuka Pharmaceutical
  • 12.5.1 Company Details
  • 12.5.2 Opioid Tolerance Treatment Product Offered
  • 12.5.3 Otsuka Pharmaceutical Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Otsuka Pharmaceutical News
• 12.6 Johnson & Johnson Services
  • 12.6.1 Company Details
  • 12.6.2 Opioid Tolerance Treatment Product Offered
  • 12.6.3 Johnson & Johnson Services Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Johnson & Johnson Services News
• 12.7 Aurobindo Pharma
  • 12.7.1 Company Details
  • 12.7.2 Opioid Tolerance Treatment Product Offered
  • 12.7.3 Aurobindo Pharma Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Aurobindo Pharma News
• 12.8 Pfizer
  • 12.8.1 Company Details
  • 12.8.2 Opioid Tolerance Treatment Product Offered
  • 12.8.3 Pfizer Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Pfizer News
• 12.9 Acorda Therapeutics
  • 12.9.1 Company Details
  • 12.9.2 Opioid Tolerance Treatment Product Offered
  • 12.9.3 Acorda Therapeutics Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Acorda Therapeutics News
• 12.10 Zydus Cadila
  • 12.10.1 Company Details
  • 12.10.2 Opioid Tolerance Treatment Product Offered
  • 12.10.3 Zydus Cadila Opioid Tolerance Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Zydus Cadila News

13 Research Findings and Conclusion

Opioids are effective analgesics prescribed to people with chronic cancer and severe pain. These opioids are generally used for short period of time. If these opioids are prescribed or taken for a longer period of time or more frequent daily doses, they create opioid tolerance in patients and hence, analgesia or desired therapeutic response is not received.

According to this study, over the next five years the Opioid Tolerance Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Opioid Tolerance Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Tolerance Treatment market by product type, application, key manufacturers and key regions and countries.

This study considers the Opioid Tolerance Treatment value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
NMDA Antagonists
Alpha2-Adrenoceptor Agonists
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals and Ambulatory Surgery Centers
Rehabilitation Centers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim International
GlaxoSmithKline
Teva Pharmaceutical Industries
Mylan
Otsuka Pharmaceutical
Johnson & Johnson Services
Aurobindo Pharma
Pfizer
Acorda Therapeutics
Zydus Cadila

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Opioid Tolerance Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Opioid Tolerance Treatment market by identifying its various subsegments.
Focuses on the key global Opioid Tolerance Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Opioid Tolerance Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Opioid Tolerance Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.